Sectors

MLYS
Mineralys Therapeutics, Inc.
28.34
1 x 19.84
1 x 36.22
bid
ask
+
0.32
1.16%
10:07 AM
timesize
Ytd-21.90%
1y-27.82%
27.90
day range
28.44
22.30
52 week range
47.65
Open28.19Prev Close28.02Low27.90High28.44Mkt Cap2.51B
Vol81.33KAvg Vol1.10MEPS-4.20P/EN/AForward P/E-11.21
Beta0.68Short Ratio11.88Inst. Own117.94%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1050-d Avg27.13200-d Avg29.001yr Est48.50

MLYS News

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Director Sells $85,740.00 in Stock
defenseworld.net
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Director Sells $85,740.00 in Stock

Mineralys Therapeutics, Inc. (NASDAQ: MLYS - Get Free Report) Director Daphne Karydas sold 3,000 sha

7 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
7 Health Care Stocks With Whale Alerts In Today's Session

benzinga.com
Reported Sunday, Mineralys Therapeutics Presents Late-Breaking Data At ENDO 2026 Showing Lorundrosta

– Lorundrostat was associated with significant reductions in heart failure risk biomarkers in a prot

benzinga.com
Mineralys to Present New Trial Data at ENDO 2026, Proteomic Analysis Selected for Late-Breaking ENDO

Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a biopharmaceutical company focused on developing medici

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
Mineralys Prices $150M Stock Offering Of 5.66M Shares At $26.50/Share, To Use Share Sale Proceeds fo

Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a biopharmaceutical company focused on developing medici

AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios
benzinga.com
AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios

AstraZeneca wins FDA approvals for Baxfendy in hypertension and Enhertu in early HER2-positive breas

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

benzinga.com
Mineralys Therapeutics Q1 EPS $(0.47), Inline

Mineralys Therapeutics (NASDAQ:MLYS) reported quarterly losses of $(0.47) per share which met the an

benzinga.com
B of A Securities Maintains Buy on Mineralys Therapeutics, Raises Price Target to $51

B of A Securities analyst Greg Harrison maintains Mineralys Therapeutics (NASDAQ:MLYS) with a Buy

benzinga.com
Mineralys Therapeutics Q4 EPS $(0.40) Beats $(0.58) Estimate

Mineralys Therapeutics (NASDAQ:MLYS) reported quarterly losses of $(0.40) per share which beat the a

Earnings Scheduled For March 12, 2026
benzinga.com
Earnings Scheduled For March 12, 2026

benzinga.com
Mineralys Therapeutics Says FDA Accepts NDA For Lorundrostat For Treatment Of Adult Patients With Hy

– The FDA assigned a PDUFA target action date of December 22, 2026 –– The NDA is based on positive d

benzinga.com
Stifel Maintains Buy on Mineralys Therapeutics, Raises Price Target to $52

Stifel analyst Annabel Samimy maintains Mineralys Therapeutics (NASDAQ:MLYS) with a Buy and raise

benzinga.com
Mineralys Therapeutics' Phase 3 Launch-HTN Trial Of Lorundrostat Featured In JAMA's Inaugural "Resea

– Launch-HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants wi

benzinga.com
HC Wainwright & Co. Maintains Buy on Mineralys Therapeutics, Raises Price Target to $56

HC Wainwright & Co. analyst Matthew Caufield maintains Mineralys Therapeutics (NASDAQ:MLYS) w

benzinga.com
Wells Fargo Maintains Overweight on Mineralys Therapeutics, Raises Price Target to $55

Wells Fargo analyst Mohit Bansal maintains Mineralys Therapeutics (NASDAQ:MLYS) with a Overweight

benzinga.com
Mineralys Therapeutics Q3 EPS $(0.52) Beats $(0.65) Estimate

Mineralys Therapeutics (NASDAQ:MLYS) reported quarterly losses of $(0.52) per share which beat the a

Earnings Scheduled For November 10, 2025
benzinga.com
Earnings Scheduled For November 10, 2025

benzinga.com
Reported Friday, Mineralys Therapeutics Showcases Broad Clinical Potential of Lorundrostat Across Ca

– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week –– Pivotal Phase 3 Launch-HTN t

benzinga.com
Uncovering Potential: Mineralys Therapeutics's Earnings Preview

benzinga.com
HC Wainwright & Co. Maintains Buy on Mineralys Therapeutics, Raises Price Target to $52

HC Wainwright & Co. analyst Matthew Caufield maintains Mineralys Therapeutics (NASDAQ:MLYS) w

benzinga.com
Mineralys Therapeutics Presents Phase 2 Explore-CKD Trial Of Lorundrostat At ASN Kidney Week 2025

~ Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in pa

benzinga.com
Wells Fargo Maintains Overweight on Mineralys Therapeutics, Raises Price Target to $50

Wells Fargo analyst Mohit Bansal maintains Mineralys Therapeutics (NASDAQ:MLYS) with a Overweight

benzinga.com
Goldman Sachs Maintains Buy on Mineralys Therapeutics, Raises Price Target to $52

Goldman Sachs analyst Richard Law maintains Mineralys Therapeutics (NASDAQ:MLYS) with a Buy and r

benzinga.com
HC Wainwright & Co. Reiterates Buy on Mineralys Therapeutics, Maintains $42 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates Mineralys Therapeutics (NASDAQ:MLYS)

benzinga.com
Mineralys Therapeutics Presents Subgroup Data From Phase 3 Launch-HTN Trial At AHA 2025, Highlightin

~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse ra

Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

benzinga.com
Jefferies Maintains Hold on Mineralys Therapeutics, Raises Price Target to $26

Jefferies analyst Dennis Ding maintains Mineralys Therapeutics (NASDAQ:MLYS) with a Hold and rais

Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

benzinga.com
Mineralys Therapeutics Commences $175M Public Offering With $26.25M Over-Allotment Option

Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a clinical-stage biopharmaceutical company focused on de

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tu

Nasdaq Down 1%; Signet Jewelers Earnings Top Views
benzinga.com
Nasdaq Down 1%; Signet Jewelers Earnings Top Views

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket

benzinga.com
B of A Securities Maintains Buy on Mineralys Therapeutics, Raises Price Target to $43

B of A Securities analyst Greg Harrison maintains Mineralys Therapeutics (NASDAQ:MLYS) with a Buy

benzinga.com
HC Wainwright & Co. Reiterates Buy on Mineralys Therapeutics, Maintains $42 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates Mineralys Therapeutics (NASDAQ:MLYS)

Nasdaq 100, S&P 500 Hit New All-Time Highs, Airlines Jump: What's Moving Markets Tuesday?
benzinga.com
Nasdaq 100, S&P 500 Hit New All-Time Highs, Airlines Jump: What's Moving Markets Tuesday?

Wall Street is in full rally mode after July’s inflation data eased fears that tariff-related cost p

benzinga.com
Earnings Scheduled For August 12, 2025

benzinga.com
Earnings Preview For Mineralys Therapeutics

benzinga.com
Earnings Scheduled For May 12, 2025

Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-

Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher
benzinga.com
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher

Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Prema

benzinga.com
Earnings Scheduled For February 12, 2025

Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Sess

Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's Pre-Market Session
benzinga.com
Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's P

Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket